HAGLR and cervical carcinoma: HAGLR was also found to upregulate zinc finger E-box binding homeobox 1 (ZEB1) through binding with miR-130a-3p to promote resistance to cisplatin (chemotherapy medication used to treat several types of cancers) in cervical cancer [38].